CAS: 544417-40-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Capadenoson REF: IN-DA00DB5CCAS: 544417-40-5 | % | To inquire | Tue 21 Jan 25 |
 | Capadenoson REF: TM-TQ0125CAS: 544417-40-5 | 98.85% - 99.62% | To inquire | Mon 27 Jan 25 |
 | Capadenoson REF: 3D-BC176871CAS: 544417-40-5 | Min. 95% | 447.00 €~1,460.00 € | Fri 31 Jan 25 |
Capadenoson
CAS:544417-40-5
Formula:
C25H18ClN5O2S2
Purity:
%
Color and Shape:
Solid
Molecular weight:
520.0257
Ref: IN-DA00DB5C
| 25mg | 183.00 € | ||
| 50mg | 235.00 € | ||
| 100mg | 591.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Capadenoson
CAS:544417-40-5
Capadenoson (BAY 68-4986) is a selective adenosine-A1 receptor agonist.
Formula:
C25H18ClN5O2S2
Purity:
98.85% - 99.62%
Color and Shape:
Solid
Molecular weight:
520.03
Ref: TM-TQ0125
| 5mg | 41.00 € | ||
| 10mg | 56.00 € | ||
| 25mg | 104.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 47.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
Ref: 3D-BC176871
| 5mg | 447.00 € | ||
| 10mg | 538.00 € | ||
| 25mg | 1,043.00 € | ||
| 50mg | 1,164.00 € | ||
| 100mg | 1,460.00 € |
Estimated delivery in United States, on Friday 31 Jan 2025
